Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report

被引：9
作者：
Guillemois, Sylvere [1 ]
Patsouris, Anne [1 ]
Peyraga, Guillaume [2 ]
Chassain, Kevin [3 ]
Le Corre, Yannick [3 ]
Campone, Mario [1 ]
Augereau, Paule [1 ]
机构：
[1] Ctr Paul Papin, Med Oncol Dept, Inst Cancerol Ouest, Angers, France
[2] Ctr Paul Papin, Radiat Therapy Dept, Inst Cancerol Ouest, Angers, France
[3] Univ Hosp Angers, Dermatol Dept, Angers, France
来源：
CLINICAL BREAST CANCER | 2018年 / 18卷 / 05期
关键词：
Cyclin-dependent kinase 4/6 inhibitor; Drug-induced vasculitis; Faslodex; Fulvestrant; Ibrance; Vasculitis treatment; RANDOMIZED CONTROLLED-TRIAL; THERAPY; LETROZOLE;
D O I：
10.1016/j.clbc.2018.07.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The efficacy and safety of palbociclib, a cyclindependent kinase 4/6 inhibitor, used in combination with fulvestrant was assessed in women with advanced breast cancer (ABC) whose disease had progressed during previous endocrine therapy, with a significant improvement of progression-free survival and good health-related quality of life. We report a case of an 80-year-old patient with ABC who presented a cutaneous and gastrointestinal vasculitis during treatment with palbociclib and fulvestrant. The skin biopsy was consistent with a leukocytoclastic vasculitis with immunoglobulin A deposits in dermal blood vessels. The symptoms disappeared with the arrest of palbociclib and fulvestrant treatment and a high dose corticotherapy. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：E755 / E758
页数：4
相关论文
共 50 条
  • [31] Palbociclib plus fulvestrant in a positive hormonal receptors metastatic breast cancer
    Lai-Tiong, F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 1032 - 1033
  • [32] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ham, Ahrong
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joohyuk
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 107 - 116
  • [33] Exemestane-Everolimus-Induced Angioedema in a Woman With Metastatic Breast Cancer: A Case Report and Review
    Grabie, Yisroel Y.
    Ahmed, Adham
    Acharya, Sudeep
    Flamenbaum, Matthew H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [34] Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial
    McCartney, Amelia
    Bonechi, Martina
    De Luca, Francesca
    Biagioni, Chiara
    Curigliano, Giuseppe
    Moretti, Erica
    Minisini, Alessandro Marco
    Bergqvist, Mattias
    Benelli, Matteo
    Migliaccio, Ilenia
    Galardi, Francesca
    Risi, Emanuela
    De Santo, Irene
    Romagnoli, Dario
    Biganzoli, Laura
    Di Leo, Angelo
    Malorni, Luca
    CLINICAL CANCER RESEARCH, 2020, 26 (09) : 2131 - 2139
  • [35] Palbociclib in Older Patients with Advanced/Metastatic Breast Cancer: A Systematic Review
    Brain, Etienne
    Chen, Connie
    Simon, Sofia
    Pasupuleti, Vinay
    Pfitzer, Kathleen Vieira
    Gelmon, Karen A.
    TARGETED ONCOLOGY, 2024, 19 (03) : 303 - 320
  • [36] Metastatic Occult Primary Lobular Breast Cancer: A Case Report
    Pouptsis, Athanasios
    Gimeno, Julia Cano
    Rubio, Carmen Martinez
    Marrades, Marta Banuls
    Sasot, Patricia Olivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [37] Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
    Orlandi, Armando
    Aroldi, Francesca
    Garutti, Mattia
    Di Dio, Carmela
    Garufi, Giovanna
    Iattoni, Elena
    Palazzo, Antonella
    Indellicati, Giulia
    Franceschini, Gianluca
    Cassano, Alessandra
    Bria, Emilio
    Tortora, Giampaolo
    BREAST JOURNAL, 2020, 26 (07) : 1458 - 1460
  • [38] Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer
    Turner, Nicholas C.
    Liu, Yuan
    Zhu, Zhou
    Loi, Sherene
    Colleoni, Marco
    Loibl, Sibylle
    DeMichele, Angela
    Harbeck, Nadia
    Andre, Fabrice
    Bayar, Mohamed Amine
    Michiels, Stefan
    Zhang, Zhe
    Giorgetti, Carla
    Arnedos, Monica
    Bartlett, Cynthia Huang
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1169 - +
  • [39] Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations
    Moser, Sarah Sharman
    Mazursky, Orr Friedman
    Shalev, Hadas
    Apter, Lior
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    FUTURE ONCOLOGY, 2023, 19 (21) : 1473 - 1483
  • [40] Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer
    Hoste, G.
    Punie, K.
    Wildiers, H.
    Beuselinck, B.
    Lefever, I.
    Van Nieuwenhuysen, E.
    Han, S. N.
    Berteloot, P.
    Concin, N.
    Salihi, R.
    Vergote, I.
    Neven, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 131 - 141
12345